Gefitinib Enhances the Antitumor Activity of CPT-11 in vitro and in vivo by Inhibiting ABCG2 but Not ABCB1: A New Clue to Circumvent Gastrointestinal Toxicity Risk

Publisher: Karger

E-ISSN: 1421-9794|59|4|260-272

ISSN: 0009-3157

Source: Chemotherapy, Vol.59, Iss.4, 2014-01, pp. : 260-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content